Amneal Pharmaceuticals Inc
NYSE:AMRX
Amneal Pharmaceuticals Inc
NYSE:AMRX
Price:
6.59 USD
-2.8%
Market Closed
Updated:
Jun 1, 2024
Amneal Pharmaceuticals Inc
Other Non-Cash Items
|
Amneal Pharmaceuticals Inc
Other Non-Cash Items Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Other Non-Cash Items Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amneal Pharmaceuticals Inc
NYSE:AMRX
|
Other Non-Cash Items
$212.1m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
17%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Non-Cash Items
-$18.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Non-Cash Items
$13.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
74%
|
|
|
Pfizer Inc
NYSE:PFE
|
Other Non-Cash Items
$5.6B
|
CAGR 3-Years
63%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Other Non-Cash Items
$12.9B
|
CAGR 3-Years
23%
|
CAGR 5-Years
48%
|
CAGR 10-Years
31%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Non-Cash Items
$3B
|
CAGR 3-Years
373%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
31%
|
See Also
What is Amneal Pharmaceuticals Inc's Other Non-Cash Items?
Other Non-Cash Items
212.1m
USD
212.1m
USD
Based on the financial report for Dec 31, 2023, Amneal Pharmaceuticals Inc's Other Non-Cash Items amounts to 212.1m USD.
What is Amneal Pharmaceuticals Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 10Y
17%
17%
Over the last year, the Other Non-Cash Items growth was 52%. The average annual Other Non-Cash Items growth rates for Amneal Pharmaceuticals Inc have been 16% over the past three years , -8% over the past five years , and 17% over the past ten years .
You don't have any saved screeners yet
